Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Compound 4 is a promising treatment for hair loss with low toxicity.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Bicalutamide shows promise for treating female hair loss.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Abatacept may help some people with alopecia areata regrow hair.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Bicalutamide may help treat female pattern hair loss.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Baricitinib improved hair loss and arthritis in a lupus patient.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.